INVION LIMITED: CHANGE OF REGISTERED OFFICE AND PRINCIPAL PLACE OF BUSINESS
Invion Limited (ASX:IVX) wishes to advise that, effective 16 March 2018, the registered office and principal place of business for the Company is:
Invion Limited
722 High Street
East Kew, VIC 3102
Australia
The contact and mailing details of the Company change to:
Invion Limited
722 High Street
East Kew, VIC 3102
Australia
Telephone: + 61 3 9081 6005
Email: investor@inviongroup.com
FOR MORE INFORMATION: Melanie Farris, Company Secretary E: investor@inviongroup.com
About Invion Limited
Invion is a clinical-stage life-sciences company that holds the license to the next-generation Photo Dynamic Therapy (PDT), PhotosoftTM, for the treatment of solid cancers. Research and clinical trials are funded by the technology licensor, The Cho Group, which provides non-dilutive funding to the Company via an R&D services agreement. Invion has operations in Australia and the US, and is listed on ASX (ASX:IVX).